Abstract Methods: The National Neurofibromatosis Foundation convened an expert task
force to review current knowledge about cardiovascular manifestations of NF1 and to make …

TO THE PRESENT, the health care of patients with neurofibromatosis (NF) has been
hampered by a lack of accurate information about NF as well as by serious …

BACKGROUND Middle aortic syndrome (MAS) is a rare clinical entity in childhood,
characterized by a severe narrowing of the distal thoracic and/or abdominal aorta, and …

This monograph, which was more than five years in preparation, represents a very detailed
account of pheochromocytoma, a tumor that is almost invariably lethal if untreated. In …

Functionally significant, nonatherosclerotic, noninflammatory, concentric and tubular
stenoses of the abdominal aorta, 4 to 16 cm in length, were encountered in five male and …

Neurofibromatosis, which was first described in 1882 by Von Recklinghausen, is a genetic
disease characterized by a neuroectodermal abnormality and by clinical manifestations of …

The topic of neurofibromatosis(NF) has evolved from one of little general interest to the
present state of intense interest by clinicians and scientists at all levels from innumerable …

RASopathies are a heterogeneous group of genetic syndromes caused by germline
mutations in a group of genes that encode components or regulators of the Ras/mitogen …

Coarctation of the abdominal aorta remains a surgically treatable cause of hypertension in
children and young adults. Average age of the patients is 21 years at the time of diagnosis …

Background. The effectiveness of percutaneous transluminal angioplasty (PTA) in renal
artery stenosis (RAS) associated with neurofibromatosis type 1 (NF1) has not been …